Spire Healthcare shares surge nearly 16%, company mulls sale
Published by Global Banking & Finance Review®
Posted on September 19, 2025
1 min readLast updated: January 21, 2026

Published by Global Banking & Finance Review®
Posted on September 19, 2025
1 min readLast updated: January 21, 2026

Spire Healthcare shares soared 16% as the company considers strategic options, including a sale, following investor pressure.
LONDON (Reuters) - Spire Healthcare shares jumped almost 16% on Friday after the British private hospital group said it was exploring strategic options, including a potential sale of the company.
Spire shares jumped to a one-year high, last up 15.7% and set for their biggest one-day rally since May 2021.
The group - which operates 38 hospitals and more than 50 clinics, medical centers and consulting rooms in the UK - said it was working with lead financial adviser Rothschild & Co.
The statement came after a Sky News report on Wednesday suggested some of Spire's investors, including activist trust Achilles AIC.L, part of Harwood Capital Management, had encouraged it to consider a sale.
(Reporting by Joice Alves; Editing by Amanda Cooper)
Spire Healthcare shares jumped almost 16% after the company announced it was exploring strategic options, including a potential sale.
Spire Healthcare is working with lead financial adviser Rothschild & Co. to explore its strategic options.
The share price increase of 15.7% marked Spire's biggest one-day rally since May 2021.
The report indicated that some of Spire's investors, including activist trust Achilles AIC.L, had encouraged the company to consider a sale.
Spire Healthcare operates 38 hospitals and more than 50 clinics, medical centers, and consulting rooms in the UK.
Explore more articles in the Finance category


